Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020

NEXT STORY
Fair-Market Value Compensation Rates for United States Endocrinology Health Care Providers 2020: Hourly and Half-Day Flat Compensation Rates for 4 Thought Leader Levels
PREV STORY
ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex Appoints Randoll Sze as Chief Financial Officer

BUFFALO, N.Y., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global ...

author_avatar
NASDAQ Market News

Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma

author_avatar
NASDAQ Market News

Chinese Center for Drug Evaluation (CDE) Cleared Taletrectinib IND and Issued Clinical Trial Authorizations for Two Phase 2 Clinical Trials in China

author_avatar
NASDAQ Market News